Clinical Trials Logo

Adenocarcinoma of the Lung clinical trials

View clinical trials related to Adenocarcinoma of the Lung.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02288026 Recruiting - Clinical trials for Squamous Cell Lung Cancer

Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer

Start date: September 2014
Phase: N/A
Study type: Observational

The purpose of this study is to compare early-stage peripheral non-small cell lung cancer lobectomy and sub-lobectomy surgery to evaluate if sub-lobectomy is as feasible and effective for the treatment of early-stage (diameter ≤2cm) peripheral non-small cell lung cancer as lobectomy.

NCT ID: NCT02264210 Recruiting - Lung Neoplasms Clinical Trials

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

CORIN
Start date: January 2015
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well icotinib works in treating patients with completely resected stage IB NSCLC harboring EGFR mutation.

NCT ID: NCT02239432 Recruiting - Clinical trials for Adenocarcinoma of the Lung

Telomere Biology in Early Adenocarcinoma of the Lung

Start date: September 2014
Phase: N/A
Study type: Observational

Early adenocarcinoma of the lung has an excellent five-year survival after resection. However, its clinical and radiologic presentation is highly variable. Traditional means for preoperative diagnosis such as Positron Emission Tomography (PET-CT) and trans-thoracic needle biopsy demonstrate unacceptable false positive and negative rates. Telomere biology is activated aberrantly is most lung cancers but has not been studied in early stages to the best of our knowledge. The objective of this study is to evaluate telomere length and activity with suspected early stage adenocarcinoma of the lung.